Lawrence Gibbs - Universal Health Independent Director

UHS Stock  USD 181.85  4.54  2.56%   

Director

Mr. Lawrence S. Gibbs is an Independent Director of Universal Health Services, Inc., since 2011. He was Chief Investment Officer at Erdos Capital since January 2017. Previously served in various portfolio manager and chief investment officer roles including portfolio manager at JP Morgan Chase Bank NA. since 2011.
Age 48
Tenure 13 years
Address Universal Corporate Center, King of Prussia, PA, United States, 19406-0958
Phone610 768 3300
Webhttps://www.uhs.com
Gibbs was Portfolio Manager, Chief Investment Office, of JP Morgan Chase Bank N.A. from 2006 to 2009.

Universal Health Management Efficiency

The company has Return on Asset of 0.0535 % which means that on every $100 spent on assets, it made $0.0535 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1182 %, implying that it generated $0.1182 on every 100 dollars invested. Universal Health's management efficiency ratios could be used to measure how well Universal Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to gain to 0.1 in 2024, whereas Return On Assets are likely to drop 0.04 in 2024. At this time, Universal Health's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 12.1 B in 2024, whereas Intangible Assets are likely to drop slightly above 85.3 M in 2024.
The company has 5.37 B in debt with debt to equity (D/E) ratio of 0.87, which is OK given its current industry classification. Universal Health Services has a current ratio of 1.24, demonstrating that it may not have the ability to pay its financial commitments when the payables are due. Debt can assist Universal Health until it has trouble settling it off, either with new capital or with free cash flow. So, Universal Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Universal Health Services sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Universal to invest in growth at high rates of return. When we think about Universal Health's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Leslie HeiszEdwards Lifesciences Corp
60
Yair RabinovitchMedigus Ltd ADR
67
Scott BurellMicrobot Medical
52
Efrat VenkertMedigus Ltd ADR
46
Yair RabinowitchMedigus Ltd ADR
71
Prattipati LaxminarainMicrobot Medical
59
Doron BirgerMedigus Ltd ADR
66
Kieran GallahueEdwards Lifesciences Corp
57
Ramona SequeiraEdwards Lifesciences Corp
55
Wesley SchackEdwards Lifesciences Corp
74
John CardisEdwards Lifesciences Corp
73
Barbara McNeilEdwards Lifesciences Corp
74
Moshe ShohamMicrobot Medical
64
Alfred LimEUDA Health Holdings
72
Jeremy StarkweatherMedigus Ltd ADR
42
Yuval YanaiMedigus Ltd ADR
65
Aviel ShapiraMedigus Ltd ADR
61
Solomon MayerMicrobot Medical
62
Nicholas ValerianiEdwards Lifesciences Corp
64
Martin MaddenMicrobot Medical
57
Yoseph BornsteinMicrobot Medical
65
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania. Universal Health operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 89000 people. Universal Health Services (UHS) is traded on New York Stock Exchange in USA. It is located in Universal Corporate Center, King of Prussia, PA, United States, 19406-0958 and employs 73,350 people. Universal Health is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

Universal Health Services Leadership Team

Elected by the shareholders, the Universal Health's board of directors comprises two types of representatives: Universal Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Universal. The board's role is to monitor Universal Health's management team and ensure that shareholders' interests are well served. Universal Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Universal Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Matthew Peterson, Executive Vice President of the company and President of Behavioral Health Division
Geraldine Geckle, Senior Resources
Matt Peterson, Executive Vice President of the company and President of Behavioral Health Division
John Herrell, Independent Presiding Director
Marc Miller, President, Director and Member of Fin. Committee
Matthew Klein, Senior Counsel
Jim Clark, Senior Division
Debra Osteen, Sr. VP and President of Behavioral Health Care Division
Edward Sim, Executive Division
Steve Filton, Chief Financial Officer, Executive Vice President, Secretary
Karen Sterner, IR Contact Officer
Lynda Smirz, Chief VP
Elliot Sussman, Independent Director
Lawrence Gibbs, Independent Director
Warren Nimetz, Director
Victor Radina, Senior Development
Robert Hotz, Independent Director
Anthony Pantaleoni, Director
Steven Filton, CFO, Senior Vice President Secretary
Marvin Pember, Executive Vice President, President of Acute Care Division
Eileen McDonnell, Lead Independent Director
Alan Miller, Executive Chairman, CEO, Member of Executive Committee and Member of Fin. Committee
Michael Nelson, Senior Services
Maria Singer, Independent Director
Thomas Day, Senior Division

Universal Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Universal Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Universal Health Investors Sentiment

The influence of Universal Health's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Universal. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Universal Health's public news can be used to forecast risks associated with an investment in Universal. The trend in average sentiment can be used to explain how an investor holding Universal can time the market purely based on public headlines and social activities around Universal Health Services. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Universal Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Universal Health's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Universal Health's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Universal Health.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Universal Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Universal Health's short interest history, or implied volatility extrapolated from Universal Health options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Universal Health Services is a strong investment it is important to analyze Universal Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Universal Health's future performance. For an informed investment choice regarding Universal Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Universal Health Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
Note that the Universal Health Services information on this page should be used as a complementary analysis to other Universal Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Universal Stock analysis

When running Universal Health's price analysis, check to measure Universal Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universal Health is operating at the current time. Most of Universal Health's value examination focuses on studying past and present price action to predict the probability of Universal Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universal Health's price. Additionally, you may evaluate how the addition of Universal Health to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Commodity Directory
Find actively traded commodities issued by global exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Money Managers
Screen money managers from public funds and ETFs managed around the world
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Is Universal Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Universal Health. If investors know Universal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Universal Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.297
Dividend Share
0.8
Earnings Share
10.24
Revenue Per Share
206.027
Quarterly Revenue Growth
0.074
The market value of Universal Health Services is measured differently than its book value, which is the value of Universal that is recorded on the company's balance sheet. Investors also form their own opinion of Universal Health's value that differs from its market value or its book value, called intrinsic value, which is Universal Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Universal Health's market value can be influenced by many factors that don't directly affect Universal Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Universal Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Universal Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Universal Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.